SynDevRx

is a Massachusetts-based biopharmaceutical company that develops polymer-based drug conjugates for the treatment of cancer and metabolic dysfunction...
Read more
SynDevRx Chairman & CEO: Bradley J Carver

Chairman & CEO

Bradley J Carver

CEO Approval Rating

85/100

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$92.7M

SynDevRx Competitors

1NexImmune
2Iovance
3Fate Therapeutics
4Aclaris
5Novartis
6Elcelyx Therapeutics
7EnBiotix
8EyePoint
9InflaRx
10Kaleido

Trending Companies